In Stock
Sitagliptin Tablets
Sitagliptin 100mg | Anti-Diabetic | Tablets
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic name: Sitagliptin Tablets 100 mg. Sitagliptin is an oral antidiabetic medicine in the dipeptidyl peptidase-4 (DPP-4) inhibitor class. This document provides general educational information and does not replace the approved product leaflet or advice from a qualified healthcare professional. The appropriate dose depends in part on kidney function and the individual treatment plan.
Product Introduction
Sitagliptin Tablets 100 mg are used to help improve blood-glucose control in adults with type 2 diabetes. Sitagliptin works by inhibiting the DPP-4 enzyme, which increases the activity of incretin hormones involved in regulating blood glucose. It is used alongside a suitable diet and physical activity and may be prescribed alone or with other diabetes medicines. The 100 mg strength is commonly used when a lower dose is required, including in some people with reduced kidney function; the prescriber must determine the appropriate dose.
1. Uses
Used to improve blood-glucose control in adults with type 2 diabetes mellitus alongside diet and exercise.
May be prescribed alone or in combination with other antidiabetic medicines, such as metformin, sulfonylureas, SGLT2 inhibitors or insulin, according to the clinician’s plan.
It is not used to treat type 1 diabetes or diabetic ketoacidosis. Do not use it for any condition unless prescribed by a qualified clinician.
2. Benefits
Helps lower blood glucose, particularly after meals, by supporting the body’s natural incretin response.
When used as part of a comprehensive diabetes plan, improved glucose control may help reduce the risk of long-term diabetes complications.
When used alone, sitagliptin generally has a low risk of causing hypoglycaemia; risk may increase when combined with insulin or a sulfonylurea.
It is generally weight-neutral for many people, although individual results can vary.
Benefits vary by person and depend on the overall treatment plan, kidney function, diet, activity and adherence.
3. Side Effects
Possible side effects include:
Headache or symptoms similar to a common cold, such as a stuffy or runny nose and sore throat.
Low blood sugar (hypoglycaemia), particularly when used with insulin or a sulfonylurea; symptoms may include sweating, shaking, hunger, dizziness, palpitations or confusion.
Stomach discomfort or diarrhoea in some people.
Important but uncommon serious reactions may include pancreatitis (persistent severe abdominal pain, sometimes spreading to the back, with or without vomiting), severe allergic reactions, severe joint pain, or bullous pemphigoid (blistering skin condition). Seek urgent medical assessment if these occur. Facial/throat swelling or difficulty breathing requires emergency help.
If you suspect low blood sugar and are awake and able to swallow safely, follow the hypoglycaemia plan provided by your healthcare team. If someone is unconscious, having a seizure or unable to swallow, do not give food or drink by mouth—seek emergency medical help.
4. Safety Advice
Use only as prescribed. Do not start, stop or change the dose without consulting your prescriber.
Kidney function affects the dose. A 100 mg dose may be appropriate for some people with reduced kidney function, but the dose must be selected by a clinician based on current renal function and local prescribing guidance.
Tell your healthcare professional if you have kidney disease, a history of pancreatitis, gallstones, high triglycerides, heart failure, or any serious allergy to sitagliptin.
If you develop persistent, severe abdominal pain—with or without vomiting—stop taking further doses until you obtain urgent medical advice, and seek assessment for possible pancreatitis.
Tell your clinician if you are pregnant, planning pregnancy or breastfeeding. Treatment may need to be reviewed.
If sitagliptin is taken with insulin or a sulfonylurea, low blood sugar may be more likely; your clinician may adjust the other medicine.
Continue recommended diet, exercise and blood-glucose monitoring. Keep scheduled medical appointments.
Tell your doctor about all medicines, vitamins, supplements and herbal products you use.
Keep out of reach of children and store according to the package instructions.
5. How It Works
Sitagliptin inhibits the DPP-4 enzyme, which normally breaks down incretin hormones such as GLP-1 and GIP. Higher levels of these hormones help the pancreas release insulin when blood glucose is elevated and reduce the release of glucagon, a hormone that raises blood glucose. The effect is glucose-dependent, so sitagliptin alone usually has a low risk of hypoglycaemia.
6. How to Use
Take exactly as prescribed and follow the leaflet supplied with your product.
Sitagliptin is usually taken once daily, with or without food, at the time advised by your prescriber.
Swallow the tablet with water.
The appropriate dose depends on kidney function and the complete treatment plan. Do not assume 100 mg is the correct dose for every person.
If you miss a dose, take it when you remember unless it is nearly time for the next dose; follow your leaflet or pharmacist’s advice. Do not take two doses together.
If you take more than prescribed, seek medical advice or contact a local poison-information service promptly.
Do not stop treatment because you feel well; discuss any changes with your clinician.
7. Quick Tips
Take the medicine consistently each day; food is not usually required for taking sitagliptin.
Keep monitoring blood glucose and HbA1c as advised by your healthcare team.
Know the symptoms of low blood sugar, especially if you also use insulin or a sulfonylurea.
Seek urgent assessment for severe persistent abdominal pain, serious allergic symptoms or a new blistering rash.
Attend kidney-function checks when advised, as this can affect the appropriate dose.
Tell your healthcare professional before starting any new prescription, over-the-counter medicine, supplement or herbal product.
Do not share your medicine with anyone else.
8. Drug Interactions
Sitagliptin has fewer clinically significant drug interactions than some medicines, but your healthcare professional should still review your full medication list.
Insulin and sulfonylureas (such as glimepiride or gliclazide): may increase the risk of hypoglycaemia when used with sitagliptin; the clinician may need to adjust doses.
Digoxin: sitagliptin can cause a small increase in digoxin exposure; monitoring may be considered in some patients.
Other diabetes medicines: combinations may be appropriate but should be directed and monitored by a clinician.
Always report medicines that affect kidney function, and tell the prescriber about all prescription and non-prescription products.
Do not start, stop or change any medicine without professional advice.
| Product Name | Sitagliptin Tablets |
| Category | All Medicines, Anti Diabetic |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 100mg |
|---|---|
| Type | Single API |
| Form | Tablets |
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
